• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov21
Chemomab Therapeutics released FY2025 Q3 earnings on November 20 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2819 (forecast USD -0.22)
04:00
Chemomab Therapeutics released FY2025 9 Months Earnings on November 20, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.2197
04:00
Aug15
Chemomab Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.355 (forecast USD -0.04)
03:00
Chemomab Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.9359
03:00
Jul1
Chemomab Therapeutics Ltd. Holds Annual General Meeting
20:06
Jun30
Chemomab Therapeutics' nebokitug Phase II Trial Results Positive
12:00

Schedules & Filings

Schedules
Filings
Nov20
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.742 M, EPS -0.2819

Aug26
Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.057 M, EPS -0.355

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More